Pharmacogeneitcs study of Asn680Ser and -29A>G of FSHR gene in controlled ovary hyperstimulation
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Poster
- By: HOU, Ning (Shandong Provincial Hospital affiliated to Shandong University, Pharmacy Setion, Jinan City, China)
- Co-author(s): Xiaohe Sun:|Junhao Yan:|Ning Hou:
The variousand unpredictable outcome of controlled ovarian hyperstimulation (COH)，whichis a critical step of Assisted Reproductive Technology(ART) has been puzzled clinicians for years. Several single-nucleotide polymorphisms (SNP) in the follicle-stimulation hormone receptor (FSHR) gene have been reported to have pharmacogenetic potential to.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.